Chaoju Eye Care Holdings Limited (HKG:2219)
Hong Kong · Delayed Price · Currency is HKD 3.050
-0.010 (-0.33%)
Aug 8, 2025, 3:59 PM HKT
Paycor HCM Revenue
In the year 2024, Chaoju Eye Care Holdings had annual revenue of 1.41B CNY with 2.62% growth. Chaoju Eye Care Holdings had revenue of 671.17M in the half year ending December 31, 2024, with 46.77% growth.
Revenue
1.41B CNY
Revenue Growth
+2.62%
P/S Ratio
1.41
Revenue / Employee
538.90K CNY
Employees
2,608
Market Cap
2.11B USD
Revenue Chart
* This company reports financials in CNY.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 1.41B | 35.95M | 2.62% |
| Dec 31, 2023 | 1.37B | 379.46M | 38.33% |
| Dec 31, 2022 | 990.04M | -7.74M | -0.78% |
| Dec 31, 2021 | 997.79M | 203.51M | 25.62% |
| Dec 31, 2020 | 794.28M | 79.61M | 11.14% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| BeOne Medicines | 32.49B |
| Hansoh Pharmaceutical Group Company | 13.05B |
| JD Health International | 61.89B |
| Innovent Biologics | 10.03B |
| Akeso | 2.26B |
| Sino Biopharmaceutical | 30.72B |
| WuXi Biologics | 19.87B |
| CSPC Pharmaceutical Group | 28.99B |